Skip to main content

Table 2 Neostigmine dose by last documented Train of Four (TOF) prior to reversal and Body Mass Index (BMI) category for cases receiving Neostigmine

From: Observational study on patterns of neuromuscular blockade reversal

 

Cases receiving first dose

Initial dose (mcg/kg)

Cases receiving second dose

Time between first and second doses (minutes)

Second dose (mcg/kg)

Cases receiving third dose

Time between second and third doses (minutes)

Third dose (mcg/kg)

Total dose (mcg/kg)

N a

Median [IQR]

N (%)a

Median [IQR]

Median [IQR]

N (%)a

Median [IQR]

Median [IQR]

Median [IQR]

Last TOF prior to reversal

 0/4

3520

37.0 [30.6, 42.4]

192 (5.5)

6 [2, 12]

20.0 [14.2, 28.1]

7 (0.2)

5 [3, 8]

22.4 [13.0, 23.9]

37.9 [30.9, 43.7]

 1/4

6956

37.1 [30.8, 42.8]

338 (4.9)

6 [2, 11]

17.3 [11.6, 24.8]

18 (0.3)

6 [3, 14]

16.8 [13.8, 27.8]

37.8 [31.3, 43.9]

 2/4

7713

37.2 [30.9, 42.2]

267 (3.5)

7 [2, 13]

15.8 [10.8, 25.0]

11 (0.1)

7 [2, 9]

11.1 [8.1, 18.1]

37.6 [31.1, 42.7]

 3/4

7133

36.8 [30.7, 41.9]

166 (2.3)

5 [1, 12]

14.5 [10.1, 22.3]

11 (0.2)

7 [3, 10]

14.7 [10.6, 17.9]

37.0 [30.8, 42.3]

 4/4

81,958

37.5 [30.6, 41.7]

1136 (1.4)

5 [1, 12]

14.7 [9.9,22.1]

73 (0.1)

3 [1, 6]

11.3 [9.3, 15.2]

37.5 [30.6, 41.7]

 Undocumented

9105

34.5 [29.4, 41.1]

217 (2.4)

6 [2, 11]

17.9 [11.1, 26.7]

10 (0.1)

9 [4, 16]

14.1 [11.6, 17.5]

35.0 [29.4, 41.5]

WHO BMI categoryb

 Underweight

2456

42.6 [36.6, 49.2]

50 (2.0)

10 [4, 15]

22.7 [19.3, 31.3]

1 (0.0)

15 [15, 15]

24.1 [24.1, 24.1]

42.8 [36.8, 50.0]

 Normal weight

32,491

39.4 [33.3, 44.4]

574 (1.8)

6 [2, 12]

19.2 [14.4, 29.9]

31 (0.1)

6 [2, 9]

17.2 [14.3, 23.9]

39.7 [33.4, 44.8]

 Overweight

35,302

37.5 [31.1, 41.7]

609 (1.7)

6 [1, 11]

15.6 [11.9, 25.5]

42 (0.1)

5 [2, 10]

13.2 [10.8, 20.0]

37.6 [31.3, 41.7]

 Class I obese

22,634

35.3 [29.7, 40.4]

488 (2.2)

5 [1, 13]

14.4 [10.1, 22.2]

26 (0.1)

3 [1, 7]

10.5 [9.4, 12.8]

35.7 [29.8, 40.7]

 Class II obese

11,321

32.7 [28.1, 39.7]

258 (2.3)

4 [1, 11]

11.9 [9.2, 19.6]

14 (0.1)

2 [1, 5]

10.3 [9.0, 13.6]

33.1 [28.4, 40.0]

 Class III obese

8973

30.5 [25.0, 37.0]

284 (3.2)

3 [0, 9]

10.4 [7.5, 16.7]

12 (0.1)

4 [1,11]

8.1 [7.0, 14.3]

30.8 [25.3, 37.5]

  1. TOF train-of-four, WHO World Health Organization, BMI body mass index
  2. aOnly among patients with TBW between 40 and 250 kg and receiving neostigmine
  3. bOnly among patients with BMI between 10 and 80